It is documented in hypothyroid patients treated with levothyroxine (LT4) [14], in menopause [7], central disorders of hypersomnolence (such as narcolepsy and idiopathic hypersomnia), multiple sclerosis, lupus erythematosus [15], depression [16], and celiac disease [18]
DiNunzio JC, Brough C, Hughey JR, Miller DA, Williams RO, McGinity JW
doi:10.1016/j.bbrc.2009.03.059, PMID: 19289108 Messina JP, Lawrence DA (1989) Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase
In addition to GLP-1 RA medications
Weight loss therapy is available at our South Tulsa location
However, the relevance of these findings to humans remains uncertain because human thyroid C-cells express GLP-1 receptors at much lower levels than rodent C-cells, suggesting potentially different susceptibility to GLP-1-mediated effects